DrugBank 6.0: the DrugBank Knowledgebase for 2024

Abstract First released in 2006, DrugBank (https://go.drugbank.com) has grown to become the ‘gold standard’ knowledge resource for drug, drug–target and related pharmaceutical information. DrugBank is widely used across many diverse biomedical research and clinical applications, and averages more than 30 million views/year. Since its last update in 2018, we have been actively enhancing the quantity and quality of the drug data in this knowledgebase. In this latest release (DrugBank 6.0), the number of FDA approved drugs has grown from 2646 to 4563 (a 72% increase), the number of investigational drugs has grown from 3394 to 6231 (a 38% increase), the number of drug–drug interactions increased from 365 984 to 1 413 413 (a 300% increase), and the number of drug–food interactions expanded from 1195 to 2475 (a 200% increase). In addition to this notable expansion in database size, we have added thousands of new, colorful, richly annotated pathways depicting drug mechanisms and drug metabolism. Likewise, existing datasets have been significantly improved and expanded, by adding more information on drug indications, drug–drug interactions, drug–food interactions and many other relevant data types for 11 891 drugs. We have also added experimental and predicted MS/MS spectra, 1D/2D-NMR spectra, CCS (collision cross section), RT (retention time) and RI (retention index) data for 9464 of DrugBank's 11 710 small molecule drugs. These and other improvements should make DrugBank 6.0 even more useful to a much wider research audience ranging from medicinal chemists to metabolomics specialists to pharmacologists.

[1]  E. Sapey,et al.  Road map for clinicians to develop and evaluate AI predictive models to inform clinical decision-making , 2023, BMJ Health & Care Informatics.

[2]  A. Zhavoronkov,et al.  AI-powered therapeutic target discovery. , 2023, Trends in pharmacological sciences.

[3]  D. Wishart,et al.  Accurate prediction of isothermal gas chromatographic Kováts retention indices. , 2023, Journal of chromatography. A.

[4]  Hilal Tayara,et al.  Artificial Intelligence in Drug Metabolism and Excretion Prediction: Recent Advances, Challenges, and Future Perspectives , 2023, Pharmaceutics.

[5]  S. McPhail,et al.  Evaluating the costs and consequences of computerized clinical decision support systems in hospitals: a scoping review and recommendations for future practice , 2023, J. Am. Medical Informatics Assoc..

[6]  R. Greiner,et al.  HMDB 5.0: the Human Metabolome Database for 2022 , 2021, Nucleic Acids Res..

[7]  Roger G. Linington,et al.  NP-MRD: the Natural Products Magnetic Resonance Database , 2021, Nucleic Acids Res..

[8]  D. Wishart,et al.  CFM-ID 4.0: More Accurate ESI-MS/MS Spectral Prediction and Compound Identification. , 2021, Analytical chemistry.

[9]  Zhiwei Zhou,et al.  Ion mobility collision cross-section atlas for known and unknown metabolite annotation in untargeted metabolomics , 2020, Nature Communications.

[10]  Gary Siuzdak,et al.  The METLIN small molecule dataset for machine learning-based retention time prediction , 2019, Nature Communications.

[11]  D. Wishart,et al.  PathBank: a comprehensive pathway database for model organisms , 2019, Nucleic Acids Res..

[12]  Eric Jonas,et al.  Rapid prediction of NMR spectral properties with quantified uncertainty , 2019, Journal of Cheminformatics.

[13]  Shuguang Yuan,et al.  Advancing Drug Discovery via Artificial Intelligence. , 2019, Trends in pharmacological sciences.

[14]  Courtney D. Corley,et al.  Deep learning to generate in silico chemical property libraries and candidate molecules for small molecule identification in complex samples. , 2019, Analytical chemistry.

[15]  Jody C. May,et al.  Predicting Ion Mobility Collision Cross-Sections Using a Deep Neural Network: DeepCCS. , 2019, Analytical chemistry.

[16]  Joseph A. Cruz,et al.  nmrML: A Community Supported Open Data Standard for the Description, Storage, and Exchange of NMR Data. , 2018, Analytical chemistry.

[17]  David S. Wishart,et al.  HMDB 4.0: the human metabolome database for 2018 , 2017, Nucleic Acids Res..

[18]  David S. Wishart,et al.  DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..

[19]  David S. Wishart,et al.  Pathways with PathWhiz , 2015, Nucleic Acids Res..

[20]  D. Wishart,et al.  DrugBank: a comprehensive resource for in silico drug discovery and exploration , 2005, Nucleic Acids Res..

[21]  P. Lampen,et al.  JCAMP-DX for NMR , 1993 .

[22]  OUP accepted manuscript , 2021, Nucleic Acids Research.